ARCHIVES

NCI Plans Trials of Burzynski’s ‘Antineoplaston’; JAMA Report Says No Antitumor Activity In Tests

This article is from The Cancer Letter archive.

Vol. 18 No. 23 | June 5, 1992

Download PDF Visit The Full Archive

Related Articles

NCI T Phase Out Support Of VA Lung Group, But Will Continue Funding VASAG

November 3, 1978

DRCCA Board Fails To Agree on New Guidelines For Cancer Control Core Grants, Will Try Again

June 25, 1981

NCAB Urges Reprogramming If Needed To Assure $150 Million For Construction Through FY 1985

June 8, 1979

Young Investigator Grants Available

July 8, 1977

FDA Authority To Remove Paclitaxel Patent Questioned.

February 9, 2001

Basic Research Group Seeks $7.9 Billion For NIH, $1.7 For NCI

July 24, 1987